Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study
Journal of Clinical Sleep Medicine · 2024
DOI: 10.5664/jcsm.11206 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Clinical Sleep Medicine, 2024. Verfasst von Sasikanth Gorantla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Illinois College of Medicine at Peoria and OSF HealthCare, Peoria, Illinois. Hauptthemen laut MEDLINE: Citric Acid, Restless Legs Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
STUDY OBJECTIVES: An estimated 3% of the population has clinically significant restless legs syndrome. Given the limited pharmacological options in the arsenal, there is a need for a therapeutic agent with a better side effect profile. METHODS: Twelve treatment naive adults (10 women and 2 men with a median age of 41.5 [32-48.5] years) with primary restless legs syndrome were recruited in our open-label pilot study; magnesium citrate 200 mg was administered daily for 8 weeks. Serum magnesium levels, International Restless Legs Syndrome Study Group Rating Scale, Kohnen quality of life scale, and multiple suggested immobilization tests (three 1-hour tests) were performed before and after supplementation. Paired t tests and Wilcoxon signed-rank tests were used for data analysis. Pearson and Spearman's analyses assessed the association between magnesium levels and restless legs syndrome variables. RESULTS: Participants had a significant reduction in International Restless Legs Syndrome Study Group Rating Scale scores (6.67 [2.33-11] P = .006) and improved Kohnen quality of life scores (8.5 [2.09-14], P = .014) without notable differences in serum magnesium levels (P = .3). The median periodic limb movements during wakefulness index (30.40 [5.20, 122.40] to 8.63 [0.32, 17.47] P = .043) and self-reported discomfort score (19 [14, 30.5] to 6 [0, 8] P = .0010) of all 3 multiple suggested immobilization test trials also demonstrated improvement. Serum magnesium levels negatively correlated with multiple suggested immobilization test self-reported scores and the periodic limb movements during wakefulness indices. CONCLUSIONS: Despite the limitations of open-label design, our study's positive results indicate the need for a placebo-controlled trial with a larger sample size. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Name: The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS); URL: https://clinicaltrials.gov/ct2/show/study/NCT04462796; Identifier: NCT04462796. CITATION: Gorantla S, Ravisankar A, Trotti LM. Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study. J Clin Sleep Med. 2024;20(8):1357-1361.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Illinois College of Medicine at Peoria and OSF HealthCare, Peoria, Illinois.
- Department of Neurology, University of California, Davis, Sacramento, California.
- Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.
Zitieren
APA
Gorantla, S., Ravisankar, A., & Trotti, L. M. (2024). Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.11206
Vancouver
Gorantla S, Ravisankar A, Trotti LM. Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study. Journal of Clinical Sleep Medicine. 2024. doi:10.5664/jcsm.11206
BibTeX
@article{Gorantla2024,
author = {Gorantla, Sasikanth and Ravisankar, Ashwath and Trotti, Lynn Marie},
title = {Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study},
journal = {Journal of Clinical Sleep Medicine},
year = {2024},
doi = {10.5664/jcsm.11206}
}
EUVIMED